English हिन्दी
Connect with us

Latest Science News

Israel cancer cure claim debunked by experts

Published

8 years ago

on

[vc_row][vc_column][vc_column_text]The Israeli biotech company, Accelerated Evolution Biotechnologies (AEBi), has announced a medical breakthrough that will cure cancer.
The company claimed that they will have the cure for this deadly disease by 2020.
Dan Aridor, of the firm Accelerated Evolution Biotechnologies Ltd. (AEBi) behind the claims, told The Jerusalem Post: “We believe we will offer in a year’s time a complete cure for cancer.”
“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” he said. “Our solution will be both generic and personal.”
The treatment called MuTaTo (a portmanteau of multi-target toxin), is based around small fragments of proteins called peptides, designed to target cancer cells.
Dr. Ilan Morad, CEO of AEBi, which is based at the Weizmann Science Park, Israel, explained to The Jerusalem Post that some existing cancer treatments hone in on targets “on or in the cancer cell.” But if the cell mutates, the treatment can become ineffective.
According to Morad, MuTaTo features a trio of peptides and a toxin that launch a three-pronged attack on cancer receptor proteins. The treatment could also have the potential to obliterate slow-growing cancer stem cells, which drugs designed to kill faster cells, can fail to, he said.
“We believe we will offer in a year’s time a complete cure for cancer,” said Aridor.
Morad said the firm had carried out in-vitro and mice experiments, and is set to launch clinical trials.
It was not clear if their results had been published in a peer-reviewed medical journal.
The news of such a big discovery spread online, other cancer experts urged the public to approach the report with caution.
Many experts who are doing research on this topic for a long period of time shared their views.
Dr. Darren Saunders, a cancer biologist at the University of New South Wales, Australia, tweeted the researchers were “selling unicorns.”


Professor Lawrence Young, director of the Warwick Cancer Research Centre at the University of Warwick, U.K., told Newsweek he was concerned the team had not appeared to publish their data in a peer-reviewed journal, and that no clinical trials had been performed. Such trials are the first step outside of the laboratory in drug development.
As per report by Newsweek, Julia Frater, senior cancer information nurse at the charity Cancer Research UK, “Unsubstantiated claims that there will be a cure for all cancers in a year are irresponsible and can be misleading for patients. This oversimplifies the fact that cancer is more than 200 different diseases, which behave differently and pose different treatment challenges. This is why finding a single cure for all cancers is unlikely.”
Professor Chris Bunce, who specializes in translational cancer biology at the University of Birmingham, U.K., told Newsweek that widely used treatments such as chemotherapy were previously regarded as “radical” and said the “technology being talked about here may be another step in that journey.”
Bunce explained why creating cancer drugs is so difficult. “On one hand cancer cells are not the big scary monsters that the general public believes them to be. More than 99.9 percent of the molecular processes within them are the same as the normal cells they originate from. So finding drugs that only target cancer cells is like finding needles in haystacks.
(Inputs from media sources)[/vc_column_text][/vc_column][/vc_row]

Related Topics:
Continue Reading

India News

PM Modi hails ISRO after successful GSLV-F17 launch, calls it proud moment

PM Modi congratulated ISRO after GSLV-F17 successfully launched EOS-05, calling the achievement a proud moment for India.

Published

2 days ago

on

September 4, 2026

By

Prime Minister Narendra Modi on Friday congratulated the Indian Space Research Organisation (ISRO) after the successful launch of the GSLV-F17 rocket carrying the EOS-05 Earth observation satellite, describing the achievement as a proud moment for the nation.

The GSLV-F17 lifted off at 2:55 a.m. IST from the Satish Dhawan Space Centre in Sriharikota, Andhra Pradesh. The EOS-05 satellite was subsequently placed into its designated sub-geosynchronous transfer orbit.

PM Modi praises ISRO’s growing capabilities

In a post on X, PM Modi said the successful mission reflected the excellence, innovation and expanding capabilities of India’s space sector.

He also highlighted the growing partnership between ISRO and Indian industry, saying it was strengthening India’s space programme and expanding capabilities across the wider space ecosystem.

The prime minister described the successful launch of GSLV-F17 carrying EOS-05 as another outstanding achievement by ISRO and a matter of national pride.

EOS-05 strengthens earth observation capabilities

According to the report, EOS-05 is India’s first-ever imaging satellite from geosynchronous orbit. The satellite is designed to provide continuous observation of the country from an altitude of nearly 36,000 km above Earth.

The mission is expected to strengthen India’s earth observation capabilities and support advanced imaging and observation applications.

ISRO Chairman Dr V Narayanan expressed satisfaction with the mission, saying the satellite was precisely injected into its intended orbit.

Mission Director Thomas Kurian described the launch as a significant milestone for the GSLV programme. He said it was the 19th flight of the GSLV and noted that EOS-05 is the heaviest satellite the launch vehicle has placed into a geosynchronous transfer orbit or sub-GTO orbit.

GSLV-F17 launch vehicle details

The GSLV-F17 stands 51.7 metres tall and has an approximate liftoff mass of 420.5 tonnes.

Science and Technology Minister Jitendra Singh also congratulated the ISRO team following the successful mission. He described EOS-05 as a state-of-the-art Earth observation satellite capable of advanced imaging across visible, infrared, multispectral and hyperspectral bands.

Continue Reading

Latest Science News

Indian-origin astronaut Anil Menon begins first mission to International Space Station

Indian-origin NASA astronaut Anil Menon has launched aboard Soyuz MS-29 on his first mission to the International Space Station, where he is expected to spend around eight months conducting research.

Published

2 months ago

on

July 14, 2026

By

Indian-origin NASA astronaut Anil Menon has embarked on his first journey into space after successfully launching aboard Russia’s Soyuz MS-29 spacecraft to the International Space Station (ISS).

The mission lifted off from the historic Baikonur Cosmodrome in Kazakhstan at 8:17 PM on Tuesday. Menon was accompanied by Russian cosmonauts Pyotr Dubrov and Anna Kikina as the three-member crew began their expedition to the orbiting laboratory.

Crew to spend about eight months aboard ISS

The Soyuz MS-29 spacecraft is expected to dock with the International Space Station a little over three hours after launch. Once aboard the ISS, the crew will carry out a range of scientific research and technology demonstration projects during their mission.

The expedition is scheduled to last approximately eight months, with the crew expected to return to Earth in 2027 after completing their planned activities in orbit.

Menon’s maiden spaceflight marks a significant milestone in his astronaut career as he joins the International Space Station crew for long-duration research and operational work.

Continue Reading

Latest Science News

Astronaut Shubhanshu Shukla to meet PM Modi after return from historic space mission

Astronaut Shubhanshu Shukla, who recently returned from the ISS as part of the Axiom-4 mission, will meet PM Modi this evening. Parliament will also hold a special discussion on his historic journey.

Published

1 year ago

on

August 18, 2025

By

Subhanshu shukla

Indian astronaut Group Captain Shubhanshu Shukla, the first Indian to visit the International Space Station (ISS), will meet Prime Minister Narendra Modi this evening at his official residence in New Delhi.

PM Modi to host meeting with astronaut

According to officials, the meeting at 7 Lok Kalyan Marg is expected to take place between 5 pm and 5:30 pm. Shukla, who arrived in India on Sunday, will also be part of the National Space Day celebrations scheduled for August 23.

Warm welcome in India

The astronaut was greeted at the airport by his family, Science and Technology Minister Jitendra Singh, Delhi Chief Minister Rekha Gupta, and hundreds of citizens waving the national flag. Shukla had been in the United States for a year, preparing for the Axiom-4 mission, which launched from Florida on June 25 and docked at the ISS the next day. He served as the mission’s pilot.

Emotional note from Shukla

Before his return, Shukla shared an emotional post on Instagram, expressing mixed feelings of leaving his space colleagues while being eager to meet his loved ones and people of India. He also quoted a song from the film Swades, which he had chosen as his anthem on the launch day.

Parliament session on India’s space journey

In honour of Shukla’s mission, the Lok Sabha is holding a special session today to discuss “India’s first astronaut aboard the ISS – critical role of space programme for Viksit Bharat by 2047.” Union minister Kiren Rijiju said the discussion would highlight the importance of India’s space achievements and future goals.

Continue Reading

Trending

© Copyright 2022 APNLIVE.com